STKE:NASDAQSol Strategies Inc. Analysis
Data as of 2026-08-31 - not real-time
$1.19
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Sol Strategies Inc. is priced at $1.19 and its moving averages line up in bearish order, the shorter trailing the longer. It has gained 1.7% over the past 30 days. RSI sits at 51.2, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near $1.00 and resistance around $1.38.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 135.3% above the current quote. Revenue is contracting at 41.2%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 80.3%, a beta of 2.95 and a maximum drawdown of 90.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 135.3% above the current quote. Revenue is contracting at 41.2%.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 80.3%, a beta of 2.95 and a maximum drawdown of 90.3%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
Top Market Events
Toronto, Ontario-- Newsfile Corp. - January 29, 2026 - SOL Strategies Inc. CSE: HODL NASDAQ: STKE the "Company" , one...Detailed price information for Sol Strategies Inc HODL-CN from The Globe and Mail including charting and trades.Nasdaq14dSOL Strategies Reports Fiscal Third Quarter Financial ResultsFirst Quarter of Segmented Reporting Reflects...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.53
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.53
- Analyst targets imply +135.3% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- Analyst targets imply +135.3% versus the current price
- Negative return on equity of -213.0%
- Revenue contracting at -41.2%
Key Metrics & Analysis
Financial Health
Revenue Growth-41.20%
P/E Ratio-170.0
ROE-212.98%
ROA-7.72%
Debt/Equity163.05
P/B Ratio1.4
Op. Cash Flow$-10743737
Free Cash Flow$3.2M
Industry P/E16.9
Technical Analysis
TrendBearish
RSI51.2
Support$1.00
Resistance$1.38
MA 20$1.14
MA 50$1.17
MA 200$1.53
MACDBullish
VolumeIncreasing
Fear & Greed Index94.5
Valuation
Target Price$2.80
Upside/Downside135.29%
GradeFair
TypeBlend
Risk Assessment
Beta2.95
Volatility80.27%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.